Singapore markets closed

Straits Times Index
3,348.87
+12.28(+0.37%)
S&P 500
5,272.53
-4.98(-0.09%)
Dow
38,433.73
-252.59(-0.65%)
Nasdaq
16,803.51
+68.49(+0.41%)
Bitcoin USD
69,309.01
+1,247.63(+1.83%)
CMC Crypto 200
1,488.89
+20.95(+1.43%)

BMY Jan 2025 38.000 put

OPR - OPR Delayed price. Currency in USD

Add to watchlist

1.9200

-0.3300

(-14.67%)

As of 09:57AM EDT. Market open.

Loading interactive chart…

Business Wire
Bristol Myers Squibb’s Breyanzi Demonstrates Clinically Meaningful Outcomes Across Broad Range of B-Cell Malignancies in New Data Presented at 2024 ASCO® Annual Meeting
PRINCETON, N.J., June 03, 2024--BMS' Breyanzi Demonstrates Clinically Meaningful Outcomes Across Broad Range of B-Cell Malignancies in New Data Presented at 2024 ASCO® Annual Meeting
Business Wire
Bristol Myers Squibb Presents Multiple New Analyses at 2024 ASCO® Annual Meeting Highlighting Opdivo and Opdivo-based Combinations in Early and Advanced Stages of Non-Small Cell Lung Cancer
PRINCETON, N.J., June 03, 2024--Bristol Myers Squibb Presents Multiple New Analyses at 2024 ASCO® Annual Meeting Highlighting Opdivo and Opdivo-based Combinations...
Business Wire
KRAZATI (adagrasib) Demonstrated Statistically Significant Improvement in Progression-Free Survival in Patients with Pretreated Locally Advanced or Metastatic KRASG12C-Mutated Non-Small Cell Lung Cancer
PRINCETON, N.J., June 01, 2024--KRAZATI (adagrasib) Demonstrated Statistically Significant Improvement in Progression-Free Survival in Patients with Pretreated Locally Advanced....